Market Cap 92.36M
Revenue (ttm) 78.23M
Net Income (ttm) -21.54M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -27.53%
Debt to Equity Ratio -3.13
Volume 70,400
Avg Vol 87,232
Day's Range N/A - N/A
Shares Out 10.07M
Stochastic %K 12%
Beta -0.30
Analysts Sell
Price Target $17.99

Latest News on OPTN

Optinose Announces 1-for-15 Reverse Stock Split

Dec 26, 2024, 7:00 AM EST - 3 months ago

Optinose Announces 1-for-15 Reverse Stock Split


OptiNose, Inc. (OPTN) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 12:47 PM EST - 5 months ago

OptiNose, Inc. (OPTN) Q3 2024 Earnings Call Transcript


Optinose Appoints Terry Kohler as Chief Financial Officer

Oct 7, 2024, 4:59 PM EDT - 6 months ago

Optinose Appoints Terry Kohler as Chief Financial Officer


OptiNose, Inc. (OPTN) Q2 2024 Earnings Call Transcript

Aug 11, 2024, 7:17 AM EDT - 8 months ago

OptiNose, Inc. (OPTN) Q2 2024 Earnings Call Transcript


OptiNose, Inc. (OPTN) Q1 2024 Earnings Call Transcript

May 17, 2024, 8:55 PM EDT - 11 months ago

OptiNose, Inc. (OPTN) Q1 2024 Earnings Call Transcript


OptiNose, Inc. (OPTN) Q4 2023 Earnings Call Transcript

Mar 7, 2024, 9:14 AM EST - 1 year ago

OptiNose, Inc. (OPTN) Q4 2023 Earnings Call Transcript


OptiNose, Inc. (OPTN) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 10:04 AM EST - 1 year ago

OptiNose, Inc. (OPTN) Q3 2023 Earnings Call Transcript


OptiNose: The Worst Has Been Avoided (Rating Upgrade)

Aug 1, 2023, 6:58 PM EDT - 1 year ago

OptiNose: The Worst Has Been Avoided (Rating Upgrade)


Optinose to Present at the Jefferies Healthcare Conference

Jun 2, 2023, 1:00 PM EDT - 1 year ago

Optinose to Present at the Jefferies Healthcare Conference


OptiNose Inc. (OPTN) Q1 2023 Earnings Call Transcript

May 11, 2023, 5:57 PM EDT - 2 years ago

OptiNose Inc. (OPTN) Q1 2023 Earnings Call Transcript


OptiNose, Inc. (OPTN) Q4 2022 Earnings Call Transcript

Mar 7, 2023, 2:22 PM EST - 2 years ago

OptiNose, Inc. (OPTN) Q4 2022 Earnings Call Transcript


Optinose Announces CEO Transition and Business Update

Jan 31, 2023, 7:00 AM EST - 2 years ago

Optinose Announces CEO Transition and Business Update


Optinose Appoints Paul Spence as Chief Commercial Officer

Dec 15, 2022, 4:30 PM EST - 2 years ago

Optinose Appoints Paul Spence as Chief Commercial Officer